0001144204-18-056564.txt : 20181031
0001144204-18-056564.hdr.sgml : 20181031
20181031192401
ACCESSION NUMBER: 0001144204-18-056564
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180924
FILED AS OF DATE: 20181031
DATE AS OF CHANGE: 20181031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wealth Strategy Holding Ltd
CENTRAL INDEX KEY: 0001723544
STATE OF INCORPORATION: K3
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20713
FILM NUMBER: 181151531
BUSINESS ADDRESS:
STREET 1: LEVEL 12, INTERNATIONAL COMMERCE CENTRE
STREET 2: 1 AUSTIN ROAD WEST
CITY: HONG KONG
STATE: K3
ZIP: HK
BUSINESS PHONE: 36698324
MAIL ADDRESS:
STREET 1: LEVEL 12, INTERNATIONAL COMMERCE CENTRE
STREET 2: 1 AUSTIN ROAD WEST
CITY: HONG KONG
STATE: K3
ZIP: HK
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000895051
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581959440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-864-2600
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ENTREMED INC
DATE OF NAME CHANGE: 19960415
3
1
tv506010_3.xml
OWNERSHIP DOCUMENT
X0206
3
2018-09-24
0
0000895051
CASI Pharmaceuticals, Inc.
CASI
0001723544
Wealth Strategy Holding Ltd
LEVEL 12 INTERNATIONAL COMMERCE CENTRE
1 AUSTIN ROAD WEST
HONG KONG
K3
HK
HONG KONG
0
0
1
0
Common Stock
8594061
D
Warrant
1.69
2017-01-23
2020-01-23
Common Stock
493827
D
Warrant
3.75
2018-04-17
2020-04-17
Common Stock
666666
D
Warrant
3.69
2018-09-17
2023-03-21
Common Stock
370370
D
Warrant
7.19
2019-03-23
2021-09-24
Common Stock
559701
D
/s/ Ken Tsang, Compliance Officer, on behalf of Wealth Strategy Holding Limited
2018-10-25